Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
50.0%
% of FBT's 31 holdings also in PBE
53.6%
% of PBE's 28 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 3.7% | 4.9% | 3.7% |
|
BIOGEN IDEC INC | 3.4% | 4.7% | 3.4% |
|
REGENERON PHARMACEUTICALS | 3.4% | 4.4% | 3.4% |
|
UNITED THERAPEUTICS CORP | 3.4% | 4.5% | 3.4% |
|
GILEAD SCIENCES INC | 3.4% | 5.3% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to PBE
 |
GENMAB A/S SPONSORED ADR | 3.5% |
|
REPLIGEN CORP | 3.5% |
|
SAREPTA THERAPEUTICS INC | 3.5% |
 |
ARGENX SE ADR | 3.4% |
 |
BIONTECH SE SPONSORED ADR | 3.4% |
|
KRYSTAL BIOTECH, INC. | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 3.4% |
|
BEIGENE LTD. SPONSORED ADR | 3.3% |
 |
ALKERMES PLC | 3.3% |
|
WATERS CORP | 3.3% |
FBT Underweight Relative to PBE
|
PROTAGONIST THERAPEUTICS, INC. | -4.1% |
|
TG THERAPEUTICS INC | -4.0% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |
|
ROYALTY PHARMA PLC CLASS A | -3.0% |
|
PTC THERAPEUTICS INC | -2.9% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
BLUEPRINT MEDICINES CORP. | -2.9% |
|
BIOCRYST PHARMACEUTICALS INC | -2.7% |
|
CAREDX, INC. | -2.6% |
|
DYNAVAX TECHNOLOGIES CORP | -2.4% |